225 related articles for article (PubMed ID: 12747452)
21. Activation of G-protein coupled fMLP or PAF receptor directly triggers glucose transporter type 1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor.
Hagi A; Hayashi H; Kishi K; Wang L; Ebina Y
J Med Invest; 2000 Feb; 47(1-2):19-28. PubMed ID: 10740976
[TBL] [Abstract][Full Text] [Related]
22. The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling.
Prossnitz ER; Quehenberger O; Cochrane CG; Ye RD
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):581-7. PubMed ID: 8373373
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of formyl peptide receptor coupling to g(i)alpha(1), g(i)alpha(2), and g(i)alpha(3).
Wenzel-Seifert K; Arthur JM; Liu HY; Seifert R
J Biol Chem; 1999 Nov; 274(47):33259-66. PubMed ID: 10559200
[TBL] [Abstract][Full Text] [Related]
24. Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.
Wenzel-Seifert K; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):509-15. PubMed ID: 12679864
[TBL] [Abstract][Full Text] [Related]
25. Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate.
Prossnitz ER; Schreiber RE; Bokoch GM; Ye RD
J Biol Chem; 1995 May; 270(18):10686-94. PubMed ID: 7738006
[TBL] [Abstract][Full Text] [Related]
26. Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands.
Vilven JC; Domalewski M; Prossnitz ER; Ye RD; Muthukumaraswamy N; Harris RB; Freer RJ; Sklar LA
J Recept Signal Transduct Res; 1998; 18(2-3):187-221. PubMed ID: 9651885
[TBL] [Abstract][Full Text] [Related]
27. Activation and nuclear translocation of ERK1/2 by the formyl peptide receptor is regulated by G protein and is not dependent on beta-arrestin translocation or receptor endocytosis.
Gripentrog JM; Miettinen HM
Cell Signal; 2005 Oct; 17(10):1300-11. PubMed ID: 16038804
[TBL] [Abstract][Full Text] [Related]
28. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
29. Continuous spectrofluorometric analysis of formyl peptide receptor ternary complex interactions.
Posner RG; Fay SP; Domalewski MD; Sklar LA
Mol Pharmacol; 1994 Jan; 45(1):65-73. PubMed ID: 8302282
[TBL] [Abstract][Full Text] [Related]
30. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
[TBL] [Abstract][Full Text] [Related]
31. Fixation traps formyl peptide receptors in high and low affinity forms that can be regulated by GTP[S] in the absence of ligand.
Domalewski MD; Guyer DA; Freer RJ; Muthukumaraswamy N; Sklar LA
J Recept Signal Transduct Res; 1996; 16(1-2):59-75. PubMed ID: 8771531
[TBL] [Abstract][Full Text] [Related]
32. Differential activation of formyl peptide receptor signaling by peptide ligands.
Bae YS; Song JY; Kim Y; He R; Ye RD; Kwak JY; Suh PG; Ryu SH
Mol Pharmacol; 2003 Oct; 64(4):841-7. PubMed ID: 14500740
[TBL] [Abstract][Full Text] [Related]
33. Critical role of N-terminal N-glycosylation for proper folding of the human formyl peptide receptor.
Wenzel-Seifert K; Seifert R
Biochem Biophys Res Commun; 2003 Feb; 301(3):693-8. PubMed ID: 12565836
[TBL] [Abstract][Full Text] [Related]
34. Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: assemblies with G proteins and arrestins.
Shi M; Bennett TA; Cimino DF; Maestas DC; Foutz TD; Gurevich VV; Sklar LA; Prossnitz ER
Biochemistry; 2003 Jun; 42(24):7283-93. PubMed ID: 12809484
[TBL] [Abstract][Full Text] [Related]
35. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding.
Mery L; Boulay F
J Biol Chem; 1994 Feb; 269(5):3457-63. PubMed ID: 8106386
[TBL] [Abstract][Full Text] [Related]
36. Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation.
Vines CM; Xue M; Maestas DC; Cimino DF; Prossnitz ER
J Immunol; 2002 Dec; 169(12):6760-6. PubMed ID: 12471107
[TBL] [Abstract][Full Text] [Related]
37. Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated HL-60 cells.
Rane MJ; Prossnitz ER; Arthur JM; Ward RA; McLeish KR
Biochem Pharmacol; 2000 Jul; 60(2):179-87. PubMed ID: 10825462
[TBL] [Abstract][Full Text] [Related]
38. IFN-gamma enhances expression of formyl peptide receptors and guanine nucleotide-binding proteins by HL-60 granulocytes.
Klein JB; Scherzer JA; McLeish KR
J Immunol; 1992 Apr; 148(8):2483-8. PubMed ID: 1560204
[TBL] [Abstract][Full Text] [Related]
39. Antibodies directed to the chemotactic factor receptor detect differences between chemotactically normal and defective neutrophils from LJP patients.
DeNardin E; DeLuca C; Levine MJ; Genco RJ
J Periodontol; 1990 Oct; 61(10):609-17. PubMed ID: 2231227
[TBL] [Abstract][Full Text] [Related]
40. Removal of human polymorphonuclear leukocyte surface sialic acid inhibits reexpression (or recycling) of formyl peptide receptors. A possible explanation for its effect on formyl peptide-induced polymorphonuclear leukocyte chemotaxis.
Perez HD; Elfman F; Lobo E
J Immunol; 1987 Sep; 139(6):1978-84. PubMed ID: 3624873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
